Most Read This Week
- ESMO 2024: Recommendations From Dr. Oliver Sartor for Prostate Cancer
- Long-Term Outcomes of Treatment With Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma
- ESMO 2024: Concurrent Adjuvant Chemoradiation Improves Locoregional Control in Early Breast Cancer
- ESMO 2024: T-DXd Yields Significant Intracranial Response in Patients With HER2-Positive Metastatic Breast Cancer With Brain Metastases
- ESMO 2024: Breast Reconstruction After Mastectomy Improved Spinal Alignment Versus Mastectomy Alone
Recently Updated
- Extended Lymphadenectomy Fails to Improve Survival in Bladder Cancer
- Progress Toward Cutting Racial Mortality Disparities Stalling, Reversing
- ASTRO: Hypofractionated Radiation Therapy Safe After Breast Reconstruction
- Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related Nausea
- Anti-CTAg Antibodies Identified in Stage I, II Melanoma